Expression and clinical significance of Tbx2 in pancreatic cancer

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 1, 2009, Pages 119-122

  Duo, Song ^a   Tiao dong, Tian ^a   Lei, Zhou ^a   Wei, Wang ^a   Hong li, Sun ^a   Xian wei, Dai ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Carcinogenesis; Pancreatic cancer; Tbx2

Indexed keywords

T BOX DOMAIN PROTEIN 2; T BOX TRANSCRIPTION FACTOR; T-BOX DOMAIN PROTEIN 2;

ADULT; AGED; ARTICLE; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-BOX DOMAIN PROTEINS;

EID: 67650930742     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Abrahams A, Mowla S, Parker MI, et al (2008). UV-mediated regulation of the anti-senescence factor Tbx2. J Biol Chem, 283, 2223-30.
2. Bandyopadhyay S, Zhan R, Chaudhuri A, et al (2006). Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med, 12, 933-8.
3. Chen R, Pan S, Aebersold R, et al (2007). Proteomics studies of pancreatic cancer. Proteomics Clin Appl, 1, 1582-91.
4. Davis E, Teng H, Bilican B, et al (2008). Ectopic Tbx2 expression results in polyploidy and cisplatin resistance. Oncogene, 27, 976-84.
5. Demay F, Bilican B, Rodriguez M, et al (2007). T-box factors: targeting to chromatin and interaction with the histone H3 N-terminal tail. Pigment Cell Res, 20, 279-87.
6. Erson AE, Niell BL, DeMers SK, et al (2001). Overexpressed genes/ESTs and characterization of distinct amplicons on 17q23 in breast cancer cells. Neoplasia, 3, 521-6.
7. Greenlee RT, Hill-Harmon MB, Murray T, et al (2001).Cancer statistics, 2001. CA Cancer J Clin, 51, 15-36.
8. Guo-Chang F, Chu-Tse W (2000).Transfer of p14ARF gene in drug-resistant human breast cancer MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance. Cancer Lett, 158, 203-10.
9. Jacobs JJ, Keblusek P, Robanus-Maandag E, et al (2000). Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet, 26, 291-9.
10. Jemal A, Thomas A, Murray T, et al (2002). Cancer statistics, 2002. CA Cancer J Clin, 52, 23-47.
11. Jemal A, Murray T, Samuels A, et al (2003). Cancer statistics, 2003. CA Cancer J Clin, 53, 5-26.
12. Kim M, Sgagias M, Deng X, et al (2004). Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression. Biochem Biophys Res Commun, 320, 138-44.
13. Mahlamaki EH, Barlund M, Tanner M, et al (2002). Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer, 35, 353-8.
14. Marsh KL, Varley JM (1998). Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. Br J Cancer, 77, 1460-8.
15. Qi T, Han J, Cui Y, et al (2008). Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas. J Clin Pathol, 61, 49-58.
16. Richter A, Niedergethmann M, Sturm JW, et al (2003). Longterm results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg, 27, 324-9.
17. Rowley M, Grothey E, Couch FJ (2004). The role of Tbx2 and Tbx3 in mammary development and tumorigenesis. J Mammary Gland Biol Neoplasia, 9, 109-18.
18. Sinclair CS, Adem C, Naderi A, et al (2002). TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. Cancer Res, 62, 3587-91.
19. Singh M, Maitra A (2007). Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology, 7, 9-19.
20. Vance KW, Carreira S, Brosch G, et al (2005). Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas. Cancer Res, 65, 2260-8.